ILTS-iLDLT-LTSI 2023 Consensus Conference: Prediction and Management of Small for Size Syndrome in LDLT (Course)
40 $
Format : MP4 (29 Videos)
File Size : 49 GB
The ILTS-iLDLT-LTSI 2023 Consensus Conference will discuss the prediction and management of Small for Size Syndrome in LDLT. The conference will cover topics such as the approach to patients with an SFSG, the incidence and biomarkers of SFSS, donor and recipient factors that increase the risk of SFSS, perioperative considerations, and treatment and management of established SFSS. The conference aims to provide recommendations and guidelines for the optimal multidisciplinary management of patients undergoing established SFSS. The two-day conference will cover various other topics related to liver transplantation. In-person only topics and sessions will not be recorded.
ILTS-iLDLT-LTSI 2023 Consensus Conference: Prediction and Management of Small for Size Syndrome in LDLT (Course)
ILTS-iLDLT-LTSI 2023 Consensus Conference: Prediction and Management of Small for Size Syndrome in LDLT
These conferences are organized by the International Liver Transplantation Society (ILTS) and will be held on Jan 27, 2023, at ITC Grand Chola, Chennai, Tamil Nadu, India.
In this Consensus Conference, we will discuss:
- The approach to patients with Small for Size Syndrome (SFSS)
- The incidence, definitions, clinical factors, and biomarkers of SFSS
- Donor and recipient factors that increase the risk of SFSS and how to optimize these factors to reduce its incidence
- Perioperative considerations in the management of a patient with SFSS
- Treatment and management of established SFSS
Learning Objectives:
- Understand the gap in current practice regarding SFSS in LDLT by reviewing published evidence
- Define criteria and prediction models for SFSS in patients undergoing LDLT with SFSS
- Identify and intervene in patients with SFSS to reduce the risk
- Provide recommendations and guidelines for the optimal management of patients with established SFSS
Expected Educational Outcomes:
The participants will have the opportunity to review and discuss research on SFSS, including selection criteria/indications, prognostic models, surveillance strategies, novel therapies, and management. They will gain insight into the current knowledge of portal hemodynamics and its practical application for SFSS in LDLT. Additionally, participants will learn about innovations that contribute to improvements in the field of LDLT.
Contents:
- Day 1 – 01 Introduction
- Day 1 – 02 Methodology
- Day 1 – 03 WG1 Diagnostic criteria – Toru Ikegami
- Day 1 – 04 Topic 1a – Presentation & voting
- Day 1 – 05 Topic 1b – Presentation & voting
- Day 1 – 06 Topic 1c – Presentation & voting
- Day 1 – 07 Working group 1
- Day 1 – 08 WG2 Preventing SFSS – Roberto Troisi
- Day 1 – 09 Topic 2a – Donor selection
- Day 1 – 10 Topic 2b – Recipient selection
- Day 1 – 11 Topic 2c
- Day 1 – 12 WG3 Anesthetic considerations – James Findlay
- Day 1 – 17 Topic 4a – Medical
- Day 1 – 18 Topic 4b – Interventional
- Day 1 – 19 Topic 4c – Retransplantation
- Day 2 – 01 ACLF Definitions – Sarin
- Day 2 – 02 – Hiroto Egawa – LT for ACLF
- Day 2 – 03 – ERAS in LT West vs East
- Day 2 – 04 – Machine perfusion
- Day 2 – 05 – Coagulation in LT – Klaus Gorlinger
- Day 2 – 06 – Cardiac monitoring in LT
- Day 2 – 07 – Liver Kidney donation – Pomfret
- Day 2 – 08 – LT for HCC PVTT Debate
- Day 2 – 09 – Altruistic donation – Cattral
- Day 2 – 10 – NAT for HCC – Chen
- Day 2 – 11 – LT for hyperoxaluria
- Day 2 – 12 – LT for cholangiocarcinoma – Mark Ghobrial
- Day 2 – 13 – LT in obese patients
- Day 2 – 15 – Renal protection in LT – Marina Berenguer
Note: In-person only topics and sessions are not recorded. Please refer to the above content for details.
Related Products
